Last updated on February 2020

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis


Find a site near you

Start Over

Research Site

Bunkyo-ku, Japan
8.1miles
  Connect »

Research Site

Shinjuku-ku, Japan
8.25miles
  Connect »

Research Site

Chiyoda-ku, Japan
9.07miles
  Connect »